ABUS vs ROP
Arbutus Biopharma Corp (ABUS) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the ABUS and ROP stock pages for the full models.
Not investment advice.